APA (7th ed.) Citation

M, M., C, O., E, Z., M, B., AM, F., A, V., . . . FR, M. (2024). Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines. Blood reviews, 65, 101180. https://doi.org/10.1016/j.blre.2024.101180

Chicago Style (17th ed.) Citation

M, Mikulska, Oltolini C, Zappulo E, Bartoletti M, Frustaci AM, Visentin A, Vitale C, and Mauro FR. "Prevention and Management of Infectious Complications in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with BTK and BCL-2 Inhibitors, Focus on Current Guidelines." Blood Reviews 65 (2024): 101180. https://doi.org/10.1016/j.blre.2024.101180.

MLA (9th ed.) Citation

M, Mikulska, et al. "Prevention and Management of Infectious Complications in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with BTK and BCL-2 Inhibitors, Focus on Current Guidelines." Blood Reviews, vol. 65, 2024, p. 101180, https://doi.org/10.1016/j.blre.2024.101180.